English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Krystal Biotech
Pacient Daily
| May 22, 2023
Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene geperpavec-svdt) for the Treatment of Dystrophic Epidermolysis Bullosa
Patient Daily
| Apr 26, 2023
Krystal Biotech to Present at Association for Research in Vision and Ophthalmology Annual Meeting
Patient Daily
| Apr 24, 2023
Krystal Biotech to Present at Association for Research in Vision and Ophthalmology Annual Meeting
Patient Daily
| Apr 24, 2023
Jeune Aesthetics Announces Dosing of First Subject in Phase 1, Cohort 3 Study of KB301 for the Improvement of Lateral Canthal Lines at Rest
Trending
+
Technology/Innovation
Patient Daily
| May 8, 2025
Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+
Technology/Innovation
Patient Daily
| May 7, 2025
OTO Forum 2025 highlights innovation in ENT
+
Pharmaceuticals
Patient Daily
| May 8, 2025
Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+
Pharmaceuticals
Patient Daily
| May 8, 2025
National Library of Medicine says compounded drugs like GLP-1 offer tailored alternatives to FDA-approved treatments
